Clinical Trials
11
Active:0
Completed:9
Trial Phases
1 Phases
Not Applicable:10
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (100.0%)China Post-Market Clinical Follow-up of FACILLE®
Completed
- Conditions
- Dermal FillerNasolabial FoldHyaluronic Acid
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- SciVision Biotech Inc.
- Target Recruit Count
- 1552
- Registration Number
- NCT05294562
Evaluate the Safety and Effectiveness of Mannitol-combined Hyaluronan Supplement in the Treatment of Knee OA
Not Applicable
Completed
- Conditions
- Hyaluronic AcidKnee Osteoarthritis
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- SciVision Biotech Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT05201040
- Locations
- 🇨🇳
Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery
Not Applicable
Terminated
- Conditions
- Trigger FingerHyaluronic Acid
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- SciVision Biotech Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT05082480
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face
Not Applicable
Completed
- Conditions
- Hyaluronic AcidLidocaineDermal FillerAging Mid-Face
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- SciVision Biotech Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04622085
- Locations
- 🇨🇳
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face
Not Applicable
Completed
- Conditions
- Dermal FillerAging Mid-FaceHyaluronic AcidLidocaine
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- SciVision Biotech Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04599335
- Locations
- 🇨🇳
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- Prev
- 1
- 2
- 3
- Next
News
No news found